Early catheter-directed portal vein thrombolysis in myeloproliferative disorder-related diffuse mesenteric venous ischemia: A case report

Table 1 Laboratory parameters and medications during hospitalization

Parameter	Time to treatment initiation (days)
	D - 0	D + 1	D + 2	D + 3	D + 4	D + 5	D + 6	D + 7	D + 8	D + 13	D + 15
CDT with urokinase (U/hour)		12000	12000	12000	14000	16000	16000	16000	12000	10000	Off
Systemic anticoagulant
Heparin pump (U/hour)	440	440	320	320	200	Off
Oral apixaban						2.5 mg twice/day
Fibrinogen (mg/dL)		684	501	624	624	551			342	460	668
APTT (second)	32.8	44.9	38.2	35.9	39.6	41.5	41.3	36.0	45.5		39.8
Lactate (mmol/L)	2.2	2.5	1.6	1.0	0.7	0.9
CK (U/L)	57		47	220	195				76	48
WBC (103/μL)	12480	14180	12030	10830	10720	8980			11110	9140	8570
Hemoglobin (g/dL)	18.8	17.0	13.7	13.5	13.4	12.4			13.7	11.1	11.4
CRP (mg/dL)	11.10		10.58		1.77	3.85	4.30
Imaging				Abdominal CT					Venography		Venography

D - 0 indicates the day of presentation to the Department of Emergency and the initiation of treatment; D + indicates the number of days after initiation of treatment. APTT: Activated partial thromboplastin time; CDT: Catheter-direct thrombolysis; CK: Creatine kinase; CRP: C-reactive protein; WBC: White blood cell.